Somnigroup International Inc.

• SGI Stock Price 24h change: +2.10%. From 92.65 USD to 94.60 USD.
• From a technical perspective, SGI is exhibiting a "Strong Buy" momentum after hitting a fresh 52-week high of $95.84. Moving averages (MA5 to MA200) and indicators like RSI (59.87) and MACD (0.29) all signal continued bullish strength as the stock remains in an uptrend, though it is nearing overbought territory.
• Somnigroup International reached a new 52-week high of $95.84 on January 21, reflecting strong investor confidence and momentum in the bedding sector.
• Leggett & Platt recently entered into a non-disclosure and standstill agreement with Somnigroup following an unsolicited acquisition proposal from SGI in December.
• Institutional interest remains high, with JPMorgan and Allspring Global Investments significantly increasing or maintaining large stakes in SGI during the recent quarter.
• The U.S. health tracker and sleep technology industry is projected to grow from $19 billion in 2024 to nearly $66 billion by 2032 as consumer demand for personalized health data surges.
• Oura and the National University of Singapore launched a joint lab on January 21 to advance personalized preventive health research using continuous biometric data from smart rings.

• SGI Stock Price 24h change: +1.09%. From 92.98 USD to 94.00 USD. This rise was driven by a record high reaching 95.46 USD earlier in the session, reflecting strong investor confidence and solid sales growth momentum.
• From a technical perspective, SGI exhibits a "Strong Buy" setup with a technical score of 7/10. The stock is in a confirmed long-term uptrend, trading above its 50-day and 200-day moving averages, though short-term RSI levels suggest it is approaching overbought territory after testing its 52-week resistance.
• Somnigroup International announced an all-stock proposal to acquire Leggett & Platt (LEG), a strategic move aimed at consolidating its supply chain and expanding its bedding manufacturing footprint.
• UBS reiterated its "Buy" rating on SGI with a price target of $110, citing potential earnings accretion from the Mattress Firm acquisition and continued market share gains in the premium sleep segment.
• Somnigroup confirmed it will report its Q4 and full-year 2025 financial results on February 17, 2026, with analysts expecting a 60%+ year-over-year revenue increase driven by omnichannel expansion.
• In the broader consumer durables and healthcare sector, NHS England launched a "sprint" initiative to clear elective surgery backlogs, potentially boosting demand for specialized hospital bedding and medical furnishings.
• RBC Capital Markets issued a cautious outlook for the medical device sector in 2026, citing cost pressures and competitive threats, while favoring "strong near-term earnings" stocks like ResMed and CSL over smaller industry peers.